Mary Ellen Frustaci - Concepedia

Author

Mary Ellen Frustaci

Janssen (United States)

Also Known As

M E Frustaci, M.E. Frustaci, Mary E. Frustaci, Mary Ellen Frustaci, Mary Ellen S. Frustaci

Publications

730

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Kyorin University Amsterdam University Medical Centers University of Calgary University of Chicago

About

Mary Ellen Frustaci is an author at Janssen (United States) specializing in gastroenterology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	109
2	Gastroenterology	3	3	109
3	Immunology	1	1	28
4	Pathology	1	1	20
5	Clinical Trials	1	1	20

Mary Ellen Frustaci

Publications

706

Citations

H-Index

Page 1

	Year	Citations
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study William J. Sandborn, Geert D’Haens, Walter Reinisch, Gastroenterology	2022	188
Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial Priscilla Hollander, Harold Bays, Julio Rosenstock, Diabetes Care	2017	106
Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist <scp>JNJ</scp>‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study Maria Alba, Jaqueline Yee, Mary Ellen Frustaci, Clinical Obesity	2021	87
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial Silvio Danese, Remo Panaccione, Brian G. Feagan, The Lancet. Gastroenterology & hepatology UrologyMoxibustionGastroenterologyDouble-blind Galaxi-1 TrialMaintenance Results	2023	61
Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist <scp>JNJ</scp>‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study Nicholas A. Di Prospero, Jaqueline Yee, Mary Ellen Frustaci, Clinical Obesity	2021	54
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis Arthur J. Mayorga, Christopher M. Flores, Jeremiah Trudeau, Scandinavian Journal of Pain	2017	47
Fulranumab for treatment of diabetic peripheral neuropathic pain Hao Wang, Gary Romano, Mary Ellen Frustaci, Neurology	2014	46
A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis Mary Jane Prior, Diane D. Harrison, Mary Ellen Frustaci Current Medical Research and Opinion	2014	30
EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES Remo Panaccione, Silvio Danese, Brian G. Feagan, Gastroenterology Chronic Inflammatory DiseasesImmunologyGastroenterologyClinical GastroenterologyThe Galaxi 2	2024	28
Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy Hao Wang, Gary Romano, Margaret Fedgchin, Clinical Journal of Pain	2016	21

Page 1